On Tuesday, Dyne Therapeutics Inc (NASDAQ: DYN) opened higher 10.28% from the last session, before settling in for the closing price of $12.65. Price fluctuations for DYN have ranged from $6.36 to $35.90 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -59.45%. Company’s average yearly earnings per share was noted -8.07% at the time writing. With a float of $109.62 million, this company’s outstanding shares have now reached $114.34 million.
Dyne Therapeutics Inc (DYN) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Dyne Therapeutics Inc is 22.94%, while institutional ownership is 71.82%. The most recent insider transaction that took place on Sep 05 ’25, was worth 35,402. In this transaction CEO & President of this company sold 2,640 shares at a rate of $13.41, taking the stock ownership to the 199,539 shares. Before that another transaction happened on Sep 04 ’25, when Company’s Chief Commercial Officer sold 894 for $13.27, making the entire transaction worth $11,863. This insider now owns 95,017 shares in total.
Dyne Therapeutics Inc (DYN) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.96 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.71) by -0.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.83 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.07% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.23% during the next five years compared to -59.45% drop over the previous five years of trading.
Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators
Check out the current performance indicators for Dyne Therapeutics Inc (DYN). In the past quarter, the stock posted a quick ratio of 16.83. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.86, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -3.53 in one year’s time.
Technical Analysis of Dyne Therapeutics Inc (DYN)
Looking closely at Dyne Therapeutics Inc (NASDAQ: DYN), its last 5-days average volume was 2.34 million, which is a drop from its year-to-date volume of 2.61 million. As of the previous 9 days, the stock’s Stochastic %D was 64.83%.
During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 82.15%, which indicates a significant decrease from 86.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.78 in the past 14 days, which was higher than the 0.73 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.48, while its 200-day Moving Average is $12.76. However, in the short run, Dyne Therapeutics Inc’s stock first resistance to watch stands at $14.56. Second resistance stands at $15.16. The third major resistance level sits at $16.06. If the price goes on to break the first support level at $13.06, it is likely to go to the next support level at $12.16. Now, if the price goes above the second support level, the third support stands at $11.56.
Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats
There are currently 142,264K shares outstanding in the company with a market cap of 1.98 billion. Presently, the company’s annual sales total 0 K according to its annual income of -317,420 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -110,860 K.
